Ibuprofen Lysine
- Product NDC
- 66993-490
- 11-digit product format
- 669930490
- Labeler code
- 66993
- Product ID
- 66993-490_67ff91a5-d5cb-4a5e-a349-07f99b1e7af0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ibuprofen lysine
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Prasco Laboratories
- Application
- NDA021903
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2016-04-14
- Substance
- IBUPROFEN LYSINE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ibuprofen Lysine
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| IBUPROFEN LYSINE | 10 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | N01ORX9D6S |
| Rxcui | 1747294 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 66993-490-36 | Ibuprofen Lysine | 3 in 1 CARTON | SOLUTION | 3 | | 12 |
| 66993-490-36 | Ibuprofen Lysine | 2 mL in 1 VIAL | SOLUTION | 2 | | 12 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 66993-490 | IBUPROFEN LYSINE SOLUTION [PRASCO LABORATORIES] | 11 | Current NDC, Legacy NDC, 2 package rows | 20240106_307431c7-12de-21e5-e054-00144ff88e88.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 66993-490-36 | 66993049036 | 3 VIAL in 1 CARTON (66993-490-36) / 2 mL in 1 VIAL | 3 vial | 2016-04-14 | 0000-00-00 | No | No | Current |